Chemoprevention with COX2 inhibitors?

被引：0
作者：
机构：
来源：
Nature Reviews Cancer | 2006年 / 6卷 / 10期
关键词：
D O I：
10.1038/nrc2005
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：748 / 748
相关论文
共 50 条
  • [31] New clues in the COX2 mystery
    Peter Kirkpatrick
    [J]. Nature Reviews Drug Discovery, 2006, 5 : 4571 - 4571
  • [32] A DISCUSSION ON CHEMOPREVENTION OF ORAL CANCER BY SELECTIVE CYCLOOXYGENASE-2 (COX-2) INHIBITORS
    Singh, A. K.
    Pandey, A.
    Tewari, M.
    Prakash, Kumar
    Shukla, H. S.
    Pandey, H. P.
    [J]. DIGEST JOURNAL OF NANOMATERIALS AND BIOSTRUCTURES, 2010, 5 (02) : 285 - 295
  • [33] Channelling of COX-2 inhibitors to patients at higher gastrointestinal risk but not at lower cardiovascular risk:: the Cox2 inhibitors and tNSAIDs description of users (CADEUS) study
    Depont, F.
    Fourrier, A.
    Merliere, Y.
    Droz, C.
    Amouretti, M.
    Begaud, B.
    Benichou, J.
    Moride, Y.
    Velo, G. P.
    Sturkenboom, M.
    Blin, P.
    Moore, N.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (08) : 891 - 900
  • [34] Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors
    Jakubowski, M
    Levy, D
    Goor-Aryeh, I
    Collins, B
    Bajwa, Z
    Burstein, R
    [J]. HEADACHE, 2005, 45 (06): : 766 - 766
  • [35] Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors
    Jakubowski, M
    Levy, D
    Goor-Aryeh, I
    Collins, B
    Bajwa, Z
    Burstein, R
    [J]. HEADACHE, 2005, 45 (07): : 850 - 861
  • [36] Differential Effect of COX1 and COX2 Inhibitors on Renal Outcomes following Ischemic Acute Kidney Injury
    Bischoff, Ariane
    Bucher, Michael
    Gekle, Michael
    Sauvant, Christoph
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2014, 40 (01) : 1 - 11
  • [37] Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors
    Jakubowski, M
    Levy, D
    Goor-Aryeh, I
    Collins, B
    Bajwa, Z
    Burstein, R
    [J]. CEPHALALGIA, 2005, 25 (10) : 844 - 845
  • [38] The role of COX-2 in oral cancer development, and chemoprevention/treatment of oral cancer by selective COX-2 inhibitors
    Wang, Z
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (14) : 1771 - 1777
  • [39] -765G>C COX2 polymorphism and bladder cancer onset: implications for chemoprevention in a Portuguese population
    Pereira, A.
    Lima, L.
    Magalhaees, S.
    Santos, L.
    Medeiros, R.
    [J]. EJC SUPPLEMENTS, 2008, 6 (12): : 35 - 36
  • [40] COX2 expression in neuroblastoma increases tumorigenicity but does not affect cell death in response to the COX2 inhibitor celecoxib
    Emma Bell
    Frida Ponthan
    Claire Whitworth
    Deborah A. Tweddle
    John Lunec
    Christopher P. F. Redfern
    [J]. Clinical & Experimental Metastasis, 2014, 31 : 651 - 659
12345